These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 35872216)
1. Reporting of Allergic Reactions During Pfizer-BioNTech BNTT162B2 Vaccination in Israel. Anis E; Preis SA; Cedar N; Tal Y; Hershkowitz I; Hershko AY J Allergy Clin Immunol Pract; 2022 Nov; 10(11):2969-2976. PubMed ID: 35872216 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk. Shavit R; Maoz-Segal R; Iancovici-Kidon M; Offengenden I; Haj Yahia S; Machnes Maayan D; Lifshitz-Tunitsky Y; Niznik S; Frizinsky S; Deutch M; Elbaz E; Genaim H; Rahav G; Levy I; Belkin A; Regev-Yochay G; Afek A; Agmon-Levin N JAMA Netw Open; 2021 Aug; 4(8):e2122255. PubMed ID: 34463744 [TBL] [Abstract][Full Text] [Related]
3. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020. ; MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(2):46-51. PubMed ID: 33444297 [TBL] [Abstract][Full Text] [Related]
4. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia. Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883 [TBL] [Abstract][Full Text] [Related]
5. COVID vaccination can be performed in patients with a history of allergic reactions to the vaccines or their components: experience from a specialist clinic in South Australia. Tunbridge M; Perkins G; Lee M; Salehi T; Ryoo D; Kette F; Smith W; Gold M; Le TA; Yuson C; Hissaria P Intern Med J; 2022 Nov; 52(11):1884-1890. PubMed ID: 35848521 [TBL] [Abstract][Full Text] [Related]
6. Risk of Second Allergic Reaction to SARS-CoV-2 Vaccines: A Systematic Review and Meta-analysis. Chu DK; Abrams EM; Golden DBK; Blumenthal KG; Wolfson AR; Stone CA; Krantz MS; Shaker M; Greenhawt M JAMA Intern Med; 2022 Apr; 182(4):376-385. PubMed ID: 35188528 [TBL] [Abstract][Full Text] [Related]
7. Cumulative Adverse Event Reporting of Anaphylaxis After mRNA COVID-19 Vaccine (Pfizer-BioNTech) Injections in Japan: The First-Month Report. Iguchi T; Umeda H; Kojima M; Kanno Y; Tanaka Y; Kinoshita N; Sato D Drug Saf; 2021 Nov; 44(11):1209-1214. PubMed ID: 34347278 [TBL] [Abstract][Full Text] [Related]
8. Side effects of Pfizer/BioNTech (BNT162b2) COVID-19 vaccine reported by the Birzeit University community. Abukhalil AD; Shatat SS; Abushehadeh RR; Al-Shami N; Naseef HA; Rabba A BMC Infect Dis; 2023 Jan; 23(1):5. PubMed ID: 36604613 [TBL] [Abstract][Full Text] [Related]
9. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines. Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336 [TBL] [Abstract][Full Text] [Related]
10. Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study. Haas EJ; McLaughlin JM; Khan F; Angulo FJ; Anis E; Lipsitch M; Singer SR; Mircus G; Brooks N; Smaja M; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S Lancet Infect Dis; 2022 Mar; 22(3):357-366. PubMed ID: 34562375 [TBL] [Abstract][Full Text] [Related]
11. Association of Self-reported High-Risk Allergy History With Allergy Symptoms After COVID-19 Vaccination. Li L; Robinson LB; Patel R; Landman AB; Fu X; Shenoy ES; Hashimoto DM; Banerji A; Wickner PG; Samarakoon U; Mancini CM; Zhang Y; Blumenthal KG JAMA Netw Open; 2021 Oct; 4(10):e2131034. PubMed ID: 34698847 [TBL] [Abstract][Full Text] [Related]
12. Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Persons Aged ≥12 Years - United States, August 31-October 23, 2022. Hause AM; Marquez P; Zhang B; Myers TR; Gee J; Su JR; Blanc PG; Thomas A; Thompson D; Shimabukuro TT; Shay DK MMWR Morb Mortal Wkly Rep; 2022 Nov; 71(44):1401-1406. PubMed ID: 36327162 [TBL] [Abstract][Full Text] [Related]
13. Management of BNT162b2 mRNA COVID-19 vaccine in children aged 5-11 years with allergies, asthma, and immunodeficiency: consensus of the Italian Society of Pediatric Allergy and Immunology (SIAIP). Novembre E; Tosca M; Caffarelli C; Calvani M; Cardinale F; Castagnoli R; Chiappini E; Cravidi C; Del Giudice MM; Duse M; Licari A; Manti S; Martelli A; Ricci G; Pingitore G; Marseglia GL Ital J Pediatr; 2022 May; 48(1):76. PubMed ID: 35578294 [TBL] [Abstract][Full Text] [Related]
14. COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocol. Patel GB; Chhiba KD; Chen MM; Guo A; Watts MM; Cullen J; Bochner BS; Grammer LC; Greenberger PA; Saltoun CA; Stevens WW; Kuang FL; Peters AT Allergy Asthma Proc; 2021 Nov; 42(6):515-521. PubMed ID: 34871159 [No Abstract] [Full Text] [Related]
16. Pfizer/BioNtech BNT162b2: adverse events and insights from an Australian mass vaccination clinic for COVID-19. Halder A; Imamura H; Condon S; Boroughs K; Nilsson SC; Anderson T; Caterson ID Intern Med J; 2022 Jan; 52(1):121-124. PubMed ID: 35060290 [TBL] [Abstract][Full Text] [Related]
17. Biphasic anaphylaxis after exposure to the first dose of Pfizer-BioNTech COVID-19 mRNA vaccine. Abi Zeid Daou C; Natout MA; El Hadi N J Med Virol; 2021 Oct; 93(10):6027-6029. PubMed ID: 34050949 [TBL] [Abstract][Full Text] [Related]
18. Anaphylaxis is a rare reaction in COVID-19 vaccination. Bellomo RG; Gallenga CE; Caraffa A; Tetè G; Ronconi G; Conti P J Biol Regul Homeost Agents; 2021; 35(3):839-842. PubMed ID: 34105336 [TBL] [Abstract][Full Text] [Related]
19. COVID-19 mRNA Vaccines Are Generally Safe in the Short Term: A Vaccine Vigilance Real-World Study Says. Chen G; Li X; Sun M; Zhou Y; Yin M; Zhao B; Li X Front Immunol; 2021; 12():669010. PubMed ID: 34093567 [TBL] [Abstract][Full Text] [Related]